The $750 pill

Bavencio, a new cancer drug approved earlier this year by the U.S. Food and Drug Administration, costs about $156,000 a year per patient.Late last year, a new muscular dystrophy drug was approved that costs about $300,000 a year per patient.And a new bladder cancer treatment called Tecentriq costs $150,000 a year per patient.And who can forget the national public relations disaster …

Please sign in to continue.

Become a valued Chicago Lawyer subscriber today and receive:

  • 12 monthly print editions mailed.
  • Access to chicagolawyermagazine.com and our e-edition.
  • Bimonthly news and informational emails.
  • Special editions such as Forty Under 40, Practice Resource Guides and much, much more!.

Call (312) 644-2394 or subscribe now.